Home › Arca Biopharma Rating Reiterated by RBC Capital
 

Keywords :   


Arca Biopharma Rating Reiterated by RBC Capital

2015-10-18 18:09:25| Biotech - Topix.net

's stock had its "sector perform" rating restated by stock analysts at RBC Capital in a research note issued to investors on Sunday, MarketBeat.com reports. They presently have a $7.00 price target on the biopharmaceutical company's stock, down from their prior price target of $8.00.

Tags: rating capital rbc arca

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »